In the pre-planned subgroup of patients who received prior chemotherapy containing oxaliplatin , the median OS was 12.7 months in the FOLFIRI group and 15.3 months in the IRIS group ( HR 0.755 ; 95 % CI 0.580-0 .983 ) .